Ebola vaccine R&D: Filling the knowledge gaps-Reference-Cited by-同舟云学术

Ebola vaccine R&D: Filling the knowledge gaps

Published:2015-12-09 Issue:317 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Medaglini Donata¹²,Harandi Ali M.³,Ottenhoff Tom H. M.⁴,Siegrist Claire-Anne⁵,Consortium VSV-EBOVAC,Agnandji Selidji Todagbe,Ahmed Rafi,Anderson Jenna,Auderset Floriane,Borgianni Luisa,Brosnahan Jessica,Ciabattini Annalisa,Engler Olivier,Haks Marielle C.,Heppner Gray,Gerlini Alice,Kremsner Peter Gottfried,Leib Stephen,Monath Thomas,Ndungu Francis,Njuguna Patricia,Page Mark,Pozzi Gianni,Rappuoli Rino,Santoro Francesco

Affiliation:

1. Laboratorio di Microbiologia Molecolare e Biotecnologia (LA.M.M.B.), Dipartimento di Biotecnologie Mediche, Università di Siena, 53100 Siena, Italy.

2. Sclavo Vaccines Association, 53100 Siena, Italy.

3. Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 7A, Gothenburg, Sweden.

4. Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.

5. Center for Vaccinology, Geneva University Hospitals and University of Geneva, 1211 Geneva, Switzerland.

Abstract

An Ebola project harnesses state-of-the-art technologies that illuminate mechanisms of vaccine immunogenicity and reactogenicity.

Funder

Bill and Melinda Gates Foundation

Wellcome Trust Foundation

German Center for Infection Research

IMI2 JU

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference19 articles.

1. WHO Ebola Virus Disease (2015); available at www.who.int/mediacentre/factsheets/fs103/en.

2. Ebola viral disease outbreak—West Africa, 2014;Dixon M. G.;MMWR Morb. Mortal. Wkly. Rep.,2014

3. A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making

4. Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak

5. Human Ebola virus infection results in substantial immune activation

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Bioscaffolds in Plastic Surgery;Natural Product Inspired Scaffolds;2024

2. A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates;Nature Microbiology;2023-01-05

3. The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination—lessons learned from the SARS-CoV-2 pandemic;Clinical and Experimental Immunology;2022-12-01

4. Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine;Vaccines;2021-01-20

5. Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon;Wiener klinische Wochenschrift;2021-01-04